Visit Lucid news for the latest in psychedelics
Research shows that psychedelics can be effective at treating a variety of mental health conditions and physical illnesses.
To learn best practices developed by harm reduction experts for the novice and intrepid psychonaut alike, start here.
Psychedelic therapy shows promise as a treatment for anxiety, including social anxiety and end-of-life anxiety
Research suggests that some psychedelic compounds may be useful in treating depression in conjunction with therapy
Studies suggest that psychedelic therapy could be an effective treatment for alcoholism and opioid dependency
Studies suggest ketamine-assisted therapy is a promising treatment for depression due to its fast-acting ability to relieve depressive symptoms.
MDMA-assisted therapy has the potential to treat PTSD due to its effects on the amygdala, the part of the brain that processes fear that’s overactive in PTSD patients.
Studies suggest that psilocybin-assisted therapy can help with smoking cessation for over a year after treatment.
Learn more about psilocybin mushrooms and smoking cessation.
Psilocybin-induced mystical experiences have been associated with reduced anxiety in terminally ill patients.
Learn more about psilocybin as an end-of-life anxiety treatment.
Research suggests that ketamine-assisted therapy may be a safe and effective treatment for anxiety disorders.
Search Psychedelic U to learn and discover.
UPDATED: August 2nd, 2023
Ketamine research also suggests it has pain relieving qualities . A 2004 study analyzed…
UPDATED: August 2nd, 2023
Ketamine is being used to treat an array of mental health conditions and substance…
UPDATED: July 21st, 2023
MDMA has the potential to be a treatment for the symptoms of PTSD for…
UPDATED: July 21st, 2023
Research suggests ketamine can help with symptoms of generalized anxiety disorder and social anxiety.…
UPDATED: July 21st, 2023
One of the most promising uses of ketamine in the mental health field is…
UPDATED: July 21st, 2023
A landmark study on the use of LSD to treat alcohol use disorder occurred…
When it comes to voting on psychedelics, there’s no messing with Texas. In this first column in the new series “The Psychedelic State(s) of America,” Noah Daly and Jack Gorsline explore the roots of Texas’ fast-moving psychedelic policy reform efforts, what the Texas Ibogaine Initiative aims to accomplish, and the future of psychedelic access in Texas beyond the scope of the state legislature.
Has the psilocybin therapy industry peaked already in Oregon? Growth is slow, and uncertainty reigns, but safeguards seem to be working.
Entrepreneurs Nick Janicki of the float tank company True REST and Robin Arnott of the “digital psychedelic” company SoundSelf are teaming up to create centers that they say will offer clinical ketamine treatment together with prep and integration services including float tanks, music, and light technologies.